Section for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, 72076, Tübingen, Germany.
Department of Radiation Oncology, University Hospital Tübingen, 72076, Tübingen, Germany.
Strahlenther Onkol. 2018 Oct;194(10):921-928. doi: 10.1007/s00066-018-1319-x. Epub 2018 May 30.
To investigate a new automatic template-based replanning approach combined with constrained optimization, which may be highly useful for a rapid plan transfer for planned or unplanned machine breakdowns. This approach was tested for prostate cancer (PC) and head-and-neck cancer (HNC) cases.
The constraints of a previously optimized volumetric modulated arc therapy (VMAT) plan were used as a template for automatic plan reoptimization for different accelerator head models. All plans were generated using the treatment planning system (TPS) Hyperion. Automatic replanning was performed for 16 PC cases, initially planned for MLC1 (4 mm MLC) and reoptimized for MLC2 (5 mm) and MLC3 (10 mm) and for 19 HNC cases, replanned from MLC2 to MLC3. EUD, D, D, and D were evaluated for targets; for OARs EUD and D were analyzed. Replanning was considered successful if both plans fulfilled equal constraints.
All prostate cases were successfully replanned. The mean relative target EUD deviation was -0.15% and -0.57% for replanning to MLC2 and MLC3, respectively. OAR sparing was successful in all cases. Replanning of HNC cases from MLC2 to MLC3 was successful in 16/19 patients with a mean decrease of -0.64% in PTV60 EUD. In three cases target doses were substantially decreased by up to -2.58% (PTV60) and -3.44% (PTV54), respectively. Nevertheless, OAR sparing was always achieved as planned.
Automatic replanning of VMAT plans for a different treatment machine by using pre-existing constraints as a template for a reoptimization is feasible and successful in terms of equal constraints.
研究一种新的基于模板的自动重新规划方法,结合约束优化,这可能对计划或计划外机器故障的快速计划转移非常有用。该方法已在前列腺癌 (PC) 和头颈部癌症 (HNC) 病例中进行了测试。
将以前优化的容积调制弧形治疗 (VMAT) 计划的约束用作不同加速器头模型自动计划重新优化的模板。所有计划均使用治疗计划系统 (TPS) Hyperion 生成。为 16 例 PC 病例进行了自动重新规划,最初计划用于 MLC1(4mm MLC),并重新优化为 MLC2(5mm)和 MLC3(10mm),为 19 例 HNC 病例进行了从 MLC2 到 MLC3 的重新规划。对目标评估 EUD、D、Dmean 和 Dmax;对 OAR 分析 EUD 和 D。如果两个计划都满足相等的约束,则认为重新规划成功。
所有前列腺病例均成功重新规划。分别向 MLC2 和 MLC3 重新规划的靶区平均相对 EUD 偏差为-0.15%和-0.57%。所有病例均成功保留 OAR。19 例 HNC 病例从 MLC2 到 MLC3 的重新规划成功率为 16/19,PTV60 EUD 平均减少-0.64%。在 3 例中,靶区剂量分别显著减少了-2.58%(PTV60)和-3.44%(PTV54)。然而,OAR 保留始终按计划实现。
使用现有约束作为重新优化的模板,对不同治疗机器的 VMAT 计划进行自动重新规划在满足相等约束的情况下是可行且成功的。